11th Feb

Interim guidance on the use of Antigen Detection Tests (ADTs)


This document provides guidance on the use of antigen detection tests (ADTs) for SARS-CoV-2 in the public health system in Ireland.

Roche Rapid Antigen Tests

Version 1.0. 29.01.2021

The majority of ADTs are rapid tests undertaken at the point of care, known as Rapid Antigen Detection Tests (RADTs); antigen detection tests can also be carried out in the laboratory. This guidance was developed by the HSE Antigen Project Evaluation Working Group (membership in Appendix A), and approved by the National Public Health Emergency Team.

Given rapidly emerging information about their use in supporting public health response, ongoing validation work, and also the pace of innovation in diagnostics, it is likely that this guidance will need to be adapted and amended over time.

Read the full report

Previous
Face mask use by healthy people in the community: Summary of Evidence.
Next
Roche Launches the SARS-CoV-2 Rapid Antigen Test Nasal